? ANIMAL SHARED RESOURCE The Wistar Cancer Center operates an AAALAC?accredited Animal Shared Resource (ASR) serving faculty from all three scientific Programs. Expert management, husbandry, custodial and veterinary staff maintain the ASR, including a modified Biosafety Level 2 (BSL2) barrier, with the following specific aims: Provide service in laboratory animal medicine and husbandry, routine animal procurement, animal health surveillance, veterinary care, inventory monitoring, quarantine housing, routine technical support and technical training for all Cancer Center investigators using animals in their research. Maintain an NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) breeding colony for the generation of immunodeficient mice. Provide access to expertise for the generation of transgenic and genetically modified mice through our inter- institutional collaboration with the transgenic mouse facility at Fox Chase Cancer Center. Provide access to the services of a full time veterinary pathologist, David Garlick, D.V.M. Administer Institutional Animal Care and Use Committee (IACUC) mandated new employee orientation and IACUC procedures training as well as aseptic technique training for new researchers. House a suite for in vivo imaging, including a PerkinElmer IVIS Spectrum CT Imaging System. Construction was completed, and the new, state-of-the-art vivarium opened in November 2013. Equipped with rack space to house more than 6,000 sterile, disposable, and individually-ventilated mouse cages, the brand new, 13,570 NSF, vivarium employs technologically-advanced, disposable, and individually-ventilated cages supported by a new HVAC system. Since 2013, an institutional investment of more than $14 million has been allocated to the ASR to fulfill the mission and research objectives of the Cancer Center (CC). This significant capital allocation allowed for the construction and fit-out of the new vivarium, including features which enhance all areas of animal care for Cancer Center investigators. Access controls include ID card swipe, biometric fingerprint scan, and security cameras. Holding rooms are equipped with new ventilated racks. Further investments include isolation cubicles, which are species independent and allow for maximum flexibility while providing the industry standard for containment and isolation. During the project period, the recruitment of 10 new CC members has driven a 47% increase in the use of murine animal models. An additional animal caretaker was hired in 2016 to meet the increasing demand for services. To streamline day-to-day operations of the ASR, a new IACUC protocol and Animal Facility Management system is being incorporated in 2018. Together, the ASR continues to play an essential role to support the scientific portfolio of all three Programs in the Cancer Center, tangibly contributing to key multidisciplinary scientific advances.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA010815-52
Application #
10145606
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-04-01
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
52
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hu, Xiaowen; Sood, Anil K; Dang, Chi V et al. (2018) The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 48:8-15
Saglam, Ozlen; Conejo-Garcia, Jose (2018) PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer. Integr Cancer Sci Ther 5:
Liu, Shujing; Zhang, Gao; Guo, Jianping et al. (2018) Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis. Nat Commun 9:5426
Duperret, Elizabeth K; Trautz, Aspen; Stoltz, Regina et al. (2018) Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo. Cancer Res 78:6363-6370
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Kugel 3rd, Curtis H; Douglass, Stephen M; Webster, Marie R et al. (2018) Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res 24:5347-5356
Reyes-Uribe, Patricia; Adrianzen-Ruesta, Maria Paz; Deng, Zhong et al. (2018) Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma. Oncogene 37:4058-4072
Bhattacharjee, Souvik; Coppens, Isabelle; Mbengue, Alassane et al. (2018) Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance. Blood 131:1234-1247
Fukumoto, Takeshi; Park, Pyoung Hwa; Wu, Shuai et al. (2018) Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer. Cell Rep 22:3393-3400
Thangavel, Chellappagounder; Boopathi, Ettickan; Liu, Yi et al. (2018) Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer. Clin Cancer Res 24:1402-1414

Showing the most recent 10 out of 741 publications